Usl Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for USL PHARMA
USL PHARMA has one hundred and three approved drugs.
Summary for Usl Pharma
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 54 |
| NDAs: | 103 |
Drugs and US Patents for Usl Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 087751-001 | Mar 29, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Usl Pharma | MYIDYL | triprolidine hydrochloride | SYRUP;ORAL | 087963-001 | Jan 18, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Usl Pharma | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 088745-001 | Mar 21, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Usl Pharma | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | CAPSULE;ORAL | 071244-001 | Jun 23, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
